Allyson Parks

Associate Attorney

aparks@gibsondunn.com
T: +1 212.351.2308
New York

Allyson Parks is a litigation associate in the New York office of Gibson, Dunn & Crutcher and a member of the firm’s Intellectual Property Practice Group.

Her practice concentrates on intellectual property and complex commercial disputes across diverse industries, including pharmaceuticals, medical devices, telecommunications, specialty chemicals and manufacturing processes, and consumer products and packaging. She has been involved in all phases of litigation and arbitration.  In addition to her work in patent litigation, Allyson has represented multiple clients in matters involving sponsored research agreements, licensing agreements, and contract manufacturing agreements.

Allyson also has significant experience with inter partes reviews and other patent office proceedings, as well as Federal Circuit appeals. Allyson has also advised clients on IP diligence in connection with licensing, freedom to operate assessments, and worldwide patent portfolio management and enforcement.

Allyson has been recognized by Best Lawyers: Ones to Watch® in America for Litigation - Intellectual Property, and Litigation – Patent (2023-2024) and by Super Lawyers as a Rising Star (2019-2025).

She received her Juris Doctor from Columbia Law School, where she was named a James Kent Scholar and served as the Bluebook editor of the Columbia Law Review. She received her Bachelor of Engineering in Chemical Engineering and Master of Engineering in Engineering Management from Stevens Institute of Technology, graduating with high honors and as a member of the engineering honor society Tau Beta Pi. 

Notable Representations – Patent Litigation:

  • Represented SharkNinja against Dyson in litigation involving hair care and vacuum patents.
  • Represented Sophos against Open Text in litigation involving software technology.
  • Represented Dell against VideoLabs in litigation involving video compression technology.
  • Represented Cubist, a subsidiary of Merck & Co., against multiple generic companies in Hatch-Waxman litigation regarding CUBICIN® RF (daptomycin RF), including successfully defending against an inter partes review.*
  • Represented Pfizer, Wyeth, and Genetics Institute in inventorship action involving patents directed to anti-PD-L1 antibodies for cancer therapies.  Also represented Pfizer and Merck KGaA in BCPIA infringement litigation concerning Bavencio® (avelumab).*
  • Represented Allergan in Hatch-Waxman litigation regarding LINZESS® (linaclotide) peptide products for the treatment of various gastrointestinal disorders.*

Notable Representations - Commercial Disputes:

  • Represented Esperion against Daiichi Sankyo in licensing agreement dispute.
  • Represented client in a high-stakes arbitration (JAMS) relating to a contract manufacturing agreement for antibody products.*
  • Represented a non-profit organization in a breach of contract arbitration (ICDR) against an international pharmaceutical company involving mRNA drug therapies, winning an award of all requested damages and attorneys’ fees.*

*Representation occurred before employment at Gibson Dunn

Allyson is admitted to practice in the State of New York, the United States District Courts for the Southern District of New York and the Eastern District of New York, and the United States Court of Appeals for the Federal Circuit. She is also registered to practice before the United States Patent and Trademark Office.

Capabilities

Credentials

Education:
  • Columbia University - 2015 Juris Doctor
  • Stevens Institute of Technology - 2012 Bachelor of Engineering
  • Stevens Institute of Technology - 2012 Master of Engineering
Admissions:
  • New York Bar